Tscan Therapeutics, Inc. · NASDAQ:TCRX
Lynx1 Capital Management LP reported a 13.10% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Lynx1 Capital Management LP reported a 13.10% stake in Tscan Therapeutics, Inc., 20,519,148 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 13.10%
- Shares
- 20,519,148
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lynx1 Capital Management LP | 13.10% | 20,519,148 |
| Weston Nichols | 13.10% | 20,519,148 |
Source
Related
- Tscan Therapeutics, Inc.
- Lynx1 Capital Management LP
- Tscan Therapeutics, Inc. shareholders
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2025
- Schedule 13G/A · Lynx1 Capital Management LP · Feb 14, 2025
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026